Cooper Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $289K | Buy |
2,603
+261
| +11% | +$28.9K | 0.03% | 307 |
|
2025
Q1 | $262K | Buy |
+2,342
| New | +$262K | 0.03% | 329 |
|
2024
Q3 | – | Sell |
-7,209
| Closed | -$495K | – | 392 |
|
2024
Q2 | $495K | Buy |
7,209
+4,463
| +163% | +$306K | 0.07% | 220 |
|
2024
Q1 | $201K | Sell |
2,746
-291
| -10% | -$21.3K | 0.03% | 339 |
|
2023
Q4 | $246K | Buy |
+3,037
| New | +$246K | 0.04% | 302 |
|
2023
Q2 | – | Sell |
-2,915
| Closed | -$242K | – | 322 |
|
2023
Q1 | $242K | Buy |
2,915
+543
| +23% | +$45.1K | 0.07% | 267 |
|
2022
Q4 | $204K | Buy |
+2,372
| New | +$204K | 0.06% | 279 |
|
2020
Q3 | – | Sell |
-4,584
| Closed | -$353K | – | 210 |
|
2020
Q2 | $353K | Buy |
4,584
+80
| +2% | +$6.16K | 0.11% | 127 |
|
2020
Q1 | $337K | Buy |
4,504
+308
| +7% | +$23K | 0.14% | 99 |
|
2019
Q4 | $273K | Buy |
4,196
+195
| +5% | +$12.7K | 0.11% | 117 |
|
2019
Q3 | $254K | Buy |
4,001
+397
| +11% | +$25.2K | 0.11% | 117 |
|
2019
Q2 | $243K | Buy |
3,604
+149
| +4% | +$10K | 0.12% | 109 |
|
2019
Q1 | $225K | Buy |
3,455
+211
| +7% | +$13.7K | 0.12% | 104 |
|
2018
Q4 | $203K | Buy |
+3,244
| New | +$203K | 0.14% | 98 |
|